Cargando…
S292: NIRMATRELVIR/RITONAVIR IN COVID-19 PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: A REPORT FROMTHE EPICOVIDEHA REGISTRY
Ejemplares similares
-
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
por: Salmanton-García, Jon, et al.
Publicado: (2023) -
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey
por: Cattaneo, Chiara, et al.
Publicado: (2022) -
COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey
por: Lamure, Sylvain, et al.
Publicado: (2022) -
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
por: Pagano, Livio, et al.
Publicado: (2022) -
P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY
por: Salmanton-García, Jon, et al.
Publicado: (2023)